Diagnosis and Management of Babesiosis, Ehrlichiosis, and IMHA in a Dog

Diagnosis of Babesiosis, Ehrlichiosis, and Immune-Mediated Hemolytic Anemia (IMHA) in a Dog. 

Shura is a 9-year-old mixed-breed female dog presented to Veterinarium Clinic. According to the owner, she had been experiencing anorexia, lethargy, and vomiting. On physical examination, based on the presenting clinical signs, anemia was suspected by Nino Kushitashvili, an internist at Veterinarium.

A complete blood count performed in the clinic’s laboratory confirmed decreased erythrocyte count and hemoglobin concentration. Thrombocytopenia and leukocytosis were also identified. The anemia was classified as critical. The hematocrit was markedly decreased compared to the lower reference limit. Given the severity of the condition, blood transfusion was considered an essential intervention.

While a suitable donor was being sought, the patient received intravenous fluid therapy, symptomatic treatment, and continuous monitoring of vital parameters.

Due to the severity of Shura’s condition, Veterinarium publicly announced the urgent need for a blood donor. Very soon, a donor was identified our beloved patient, Luna, a Labrador who donated blood and gave Shura a chance to survive. 

This case inspired us to establish the Veterinarium Donor Superheroes Club. Luna became its very 1st member and will receive a lifetime 20% discount on all our services. 

The blood transfusion was administered over a period of 4 hours. Following the procedure, Shura showed clear clinical improvement, she became more active and resumed eating.

However, due to immunological mechanisms, transfused erythrocytes may be destroyed after a certain period of time, meaning that the clinical improvement can be temporary. Therefore, identifying the underlying cause of the anemia and initiating targeted treatment was critically important.

Further diagnostic testing was performed based on Nino Kushitashvili’s clinical decision. The patient was ultimately diagnosed with Babesia-associated immune-mediated hemolytic anemia (IMHA) and ehrlichiosis. IMHA is a condition in which the animal’s immune system targets and destroys circulating red blood cells, leading to hemolytic anemia.

Shura’s treatment included immunosuppressive therapy. Ongoing laboratory monitoring has shown a positive response, with all parameters currently within normal ranges. The patient continues prescribed treatment at home.